Evaxion Biotech As Stock Today
| EVAX Stock | USD 1.86 0.01 0.54% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Evaxion Biotech is trading at 1.86 as of the 20th of March 2025; that is 0.54 percent up since the beginning of the trading day. The stock's open price was 1.85. Evaxion Biotech has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Evaxion Biotech AS, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company was incorporated in 2008 and is headquartered in Hrsholm, Denmark. The company has 5.58 M outstanding shares of which 58.59 K shares are currently shorted by private and institutional investors with about 2.07 trading days to cover. More on Evaxion Biotech AS
Moving together with Evaxion Stock
Moving against Evaxion Stock
Evaxion Stock Highlights
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Evaxion Biotech AS (EVAX) is traded on NASDAQ Exchange in USA. It is located in Dr. Neergaards Vej, Horsholm, Denmark, 2970 and employs 49 people. Evaxion Biotech is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.28 M. Evaxion Biotech AS conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.58 M outstanding shares of which 58.59 K shares are currently shorted by private and institutional investors with about 2.07 trading days to cover.
Evaxion Biotech AS currently holds about 25.25 M in cash with (17.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.06.
Check Evaxion Biotech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Evaxion Biotech AS is $13.28 Million. Evaxion Biotech AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Evaxion Ownership Details
Evaxion Biotech AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Evaxion Biotech market risk premium is the additional return an investor will receive from holding Evaxion Biotech long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | 0.646 | |||
| Treynor Ratio | (0.76) |
Evaxion Stock Against Markets
Evaxion Biotech Corporate Management
| DMSC MD | Chief Officer | Profile | |
| Christian MSc | Chief Officer | Profile | |
| Jrgen EMBA | Head Board | Profile | |
| Bo Karmark | Chief Officer | Profile | |
| Jesper Nissen | Chief Officer | Profile | |
| Thomas Schmidt | Interim Officer | Profile |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.